Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jialing Lin

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
European Journal of Clinical Pharmacology|July 14, 2023
Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014-2022)Jialing Lin, Sallie-Anne Pearson, Jerry R Greenfield, et al.
European Journal of Preventive Cardiology|October 3, 2025
Social determinants of health in cancer survivors and the risk of cardiovascular eventsShunxuan Yan, Yingsi Hu, Weiwen Su, et al.
Nature Communications|August 25, 2021
PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domainMaorong Wen, Yunlei Cao, Bin Wu, et al.
The Journal of Biological Chemistry|March 12, 2014
After embedding in membranes antiapoptotic Bcl-XL protein binds both Bcl-2 homology region 3 and helix 1 of proapoptotic Bax protein to inhibit apoptotic mitochondrial permeabilizationJingzhen Ding, Blaine H M Mooers, Zhi Zhang, et al.
British Journal of Clinical Pharmacology|September 3, 2024
Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022Tamara Y Milder, Jialing Lin, Sallie-Anne Pearson, et al.
Frontiers in Public Health|November 3, 2025
Lessons learned from Vietnam's first COVID-19 vaccine rollout: tackling vaccine hesitancy and misinformation for future pandemic responsesNgoc Minh Tam Bui, Hong Trang Nguyen, Bich Thuy Duong, et al.
Campbell Systematic Reviews|June 29, 2026
PROTOCOL: Utilisation of Genetics and Genomics in Primary Care: Protocol for an Evidence and Gap MapBraulio Mark Valencia, Jialing Lin, Rafal Chomik, et al.
Diabetes, Obesity & Metabolism|April 15, 2024
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, AustraliaJuliana de Oliveira Costa, Jialing Lin, Tamara Y Milder, et al.
The Journal of Biological Chemistry|April 13, 2010
Bax forms an oligomer via separate, yet interdependent, surfacesZhi Zhang, Weijia Zhu, Suzanne M Lapolla, et al.
The Journal of Biological Chemistry|November 9, 2011
Natural diterpenoid compound elevates expression of Bim protein, which interacts with antiapoptotic protein Bcl-2, converting it to proapoptotic Bax-like moleculeLixia Zhao, Feng He, Haiyang Liu, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Clinical Pharmacology|July 14, 2023
Trends in use of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA) in Australia in the era of increased evidence of their cardiovascular benefits (2014-2022)Jialing Lin, Sallie-Anne Pearson, Jerry R Greenfield, et al.
European Journal of Preventive Cardiology|October 3, 2025
Social determinants of health in cancer survivors and the risk of cardiovascular eventsShunxuan Yan, Yingsi Hu, Weiwen Su, et al.
Nature Communications|August 25, 2021
PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domainMaorong Wen, Yunlei Cao, Bin Wu, et al.
The Journal of Biological Chemistry|March 12, 2014
After embedding in membranes antiapoptotic Bcl-XL protein binds both Bcl-2 homology region 3 and helix 1 of proapoptotic Bax protein to inhibit apoptotic mitochondrial permeabilizationJingzhen Ding, Blaine H M Mooers, Zhi Zhang, et al.
British Journal of Clinical Pharmacology|September 3, 2024
Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022Tamara Y Milder, Jialing Lin, Sallie-Anne Pearson, et al.
Frontiers in Public Health|November 3, 2025
Lessons learned from Vietnam's first COVID-19 vaccine rollout: tackling vaccine hesitancy and misinformation for future pandemic responsesNgoc Minh Tam Bui, Hong Trang Nguyen, Bich Thuy Duong, et al.
Campbell Systematic Reviews|June 29, 2026
PROTOCOL: Utilisation of Genetics and Genomics in Primary Care: Protocol for an Evidence and Gap MapBraulio Mark Valencia, Jialing Lin, Rafal Chomik, et al.
Diabetes, Obesity & Metabolism|April 15, 2024
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, AustraliaJuliana de Oliveira Costa, Jialing Lin, Tamara Y Milder, et al.
The Journal of Biological Chemistry|April 13, 2010
Bax forms an oligomer via separate, yet interdependent, surfacesZhi Zhang, Weijia Zhu, Suzanne M Lapolla, et al.
The Journal of Biological Chemistry|November 9, 2011
Natural diterpenoid compound elevates expression of Bim protein, which interacts with antiapoptotic protein Bcl-2, converting it to proapoptotic Bax-like moleculeLixia Zhao, Feng He, Haiyang Liu, et al.
Pageof 11